Skip to main content

Advertisement

SpringerLink
Log in

Primary small bowel adenomas and adenocarcinomas—recent advances

  • Review and Perspectives
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

The small intestine represents 75% of the length and 90% of the absorptive surface area of the gastrointestinal tract (GIT), yet only 2% of digestive system cancers occur at this site. Adenocarcinoma accounts for half of small bowel malignancies. There have been a number of important recent advances in our understanding, classification and treatment of small bowel tumours. Over recent years, ampullary tumours have become recognised as a form of small bowel carcinoma, distinct from head of pancreas and lower biliary tract tumours. This is reflected in separate TNM systems and increasing interest in separating intestinal from pancreatobiliary subtypes. The recognition of the importance of microsatellite (MSI) status and the advent of molecular pathology has also changed our approach to these neoplasms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Schottenfeld D, Beebe-Dimmer JL, Vigneau FD (2009) The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol 19:58–69

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS (2009) Small bowel cancer in the United States: changes in epidemiology, treatment and survival over the last 20 years. Ann Surg 249:63–71

    Article  PubMed  Google Scholar 

  3. Genta RM, Feagins LA (2013) Advanced precancerous lesions in the small bowel mucosa. Best Pract Res Clin Gastroenterol 27:225–233

    Article  PubMed  Google Scholar 

  4. Perzin KH, Bridge MF (1981) Adenomas of the small intestine: a clinicopathologic review of 51 cases and a study of their relationship to carcinoma. Cancer 48:799–819

    Article  PubMed  CAS  Google Scholar 

  5. Brosens LA, Keller JJ, Offerhaus GJ, Goggins M, Giardiello FM (2005) Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut 54:1034–1043

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Rosty C, Campbell C, Clendenning M, Bettington M, Buchanan DD, Brown IS (2014) Do serrated neoplasms of the small intestine represent a distinctive entity? Pathological findings and molecular alterations in a series of 13 cases. Histopathology 66:333–342

  7. Ushiku T, Arnason T, Fukayama M, Lauwers GY (2014) Extra-ampullary duodenal adenocarcinoma. Am J Surg Pathol 38:1484–1493

    Article  PubMed  Google Scholar 

  8. Kadmon M, Tandara A, Herfarth C (2001) Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg polyposis register. Int J Color Dis 16:63–75

    Article  CAS  Google Scholar 

  9. Agaimy A, Vassos N, Croner RS (2012) Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen’s disease): clinicopathological spectrum with pathogenetic considerations. Int J Clin Exp Pathol 5:852–862 Review

    PubMed  PubMed Central  Google Scholar 

  10. Kastrinos F, Syngal S (2011) Inherited colorectal cancer syndromes. Cancer J 17:405–415

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Haselkorn T, Whittemore AS, Lilienfeld DE (2005) Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control 16:781–787

    Article  PubMed  Google Scholar 

  12. Arber N, Neugut AI, Weinstein IB, Holt P (1997) Molecular genetics of small bowel cancer. Cancer Epidemiol Biomark Prev 6:745–748

    CAS  Google Scholar 

  13. Sellner F (1990) Investigations on the significance of the adenoma-carcinoma sequence in the small bowel. Cancer 66:702–715

    Article  PubMed  CAS  Google Scholar 

  14. Delaunoit T, Neczyporenko F, Limburg PJ, Erlichman C (2005) Pathogenesis and risk factors of small bowel adenocarcinoma: a colorectal cancer sibling? Am J Gastroenterol 100:703–710

    Article  PubMed  Google Scholar 

  15. Chen CC, Neugut AI, Rotterdam H (1994) Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomark Prev 3:205–207

    CAS  Google Scholar 

  16. Pan SY, Morrison H (2011) Epidemiology of cancer of the small intestine. World J Gastrointest Oncol 3:33–42

    Article  PubMed  PubMed Central  Google Scholar 

  17. Lowenfels AB (1973) Why are small-bowel tumours so rare? Lancet 1:24–26

    Article  PubMed  CAS  Google Scholar 

  18. Sanders LM, Henderson CE, Hong MY, Barhoumi R, Burghardt RC, Carroll RJ, Turner ND, Chapkin RS, Lupton JR (2004) Pro-oxidant environment of the colon compared to the small intestine may contribute to greater cancer susceptibility. Cancer Lett 208:155–161

    Article  PubMed  CAS  Google Scholar 

  19. DiSario JA, Burt RW, Vargas H, McWhorter WP (1994) Small bowel cancer: epidemiological and clinical characteristics from a population-based registry. Am J Gastroenterol 89:699–701

    PubMed  CAS  Google Scholar 

  20. Ciresi DL, Scholten DJ (1995) The continuing clinical dilemma of primary tumors of the small intestine. Am Surg 61:698–702 discussion 702-693

    PubMed  CAS  Google Scholar 

  21. Schirmacher P, Buchler MW (2008) Ampullary adenocarcinoma—differentiation matters. BMC Cancer 8(251)

  22. Schwameis K, Schoppmann SF, Stift J, Schwameis M, Stift A (2014) Small bowel adenocarcinoma—terra incognita: a demand for cross-national pooling of data. Oncol Lett 7:1613–1617

    Article  PubMed  PubMed Central  Google Scholar 

  23. Lowenfels AB (1978) Does bile promote extra-colonic cancer? Lancet 2:239–241

    Article  PubMed  CAS  Google Scholar 

  24. Ross RK, Hartnett NM, Bernstein L, Henderson BE (1991) Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen? Br J Cancer 63:143–145

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Hatzaras I, Palesty JA, Abir F, Sullivan P, Kozol RA, Dudrick SJ, Longo WE (2007) Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the Connecticut Tumor Registry. Arch Surg 142:229–235

    Article  PubMed  Google Scholar 

  26. Bauer RL, Palmer ML, Bauer AM, Nava HR, Douglass HO, Jr. (1994) Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment, and prognosis. Ann Surg Oncol 1;183–188

  27. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J (2004) Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 101:518–526

    Article  PubMed  Google Scholar 

  28. Talamonti MS, Goetz LH, Rao S, Joehl RJ (2002) Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg 137:564–570 discussion 570-561

    Article  PubMed  Google Scholar 

  29. Howe JR, Karnell LH, Menck HR, Scott-Conner C (1999) The American College of Surgeons commission on cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the national cancer data base, 1985-1995. Cancer 86:2693–2706

    Article  PubMed  CAS  Google Scholar 

  30. Overman MJ, Hu CY, Wolff RA, Chang GJ (2010) Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the surveillance, epidemiology, and end results database. Cancer 116:5374–5382

    Article  PubMed  Google Scholar 

  31. Balmforth DC, Phillips RK, Clark SK (2012) Advanced duodenal disease in familial adenomatous polyposis: how frequently should patients be followed up after successful therapy? Familial Cancer 11:553–557

    Article  PubMed  Google Scholar 

  32. Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK (1989) Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 2:783–785

    Article  PubMed  CAS  Google Scholar 

  33. Xie J (2008) Cancer in inflammatory bowel disease. World J Gastroenterol 14:378–389

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Egan L, D’Inca R, Jess T, Pellino G, Carbonnel F, Bokemeyer B, Harbord M, Nunes P, van der Woude J, Selvaggi F, Triantafillidis J (2014) Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (ii). J Crohn’s Colitis 8:19–30

    Article  Google Scholar 

  35. Svrcek M, Piton G, Cosnes J, Beaugerie L, Vermeire S, Geboes K, Lemoine A, Cervera P, el-Murr N, Dumont S, Scriva A, Lascols O, Ardizzone S, Fociani P, Savoye G, le Pessot F, Novacek G, Wrba F, Colombel JF, Leteurtre E, Bouhnik Y, Cazals-Hatem D, Cadiot G, Diebold MD, Rahier JF, Delos M, Fléjou JF, Carbonnel F (2014) Small bowel adenocarcinomas complicating Crohn’s disease are associated with dysplasia: a pathological and molecular study. Inflamm Bowel Dis 20:1584–1592

    Article  PubMed  Google Scholar 

  36. Piton G, Cosnes J, Monnet E, Beaugerie L, Seksik P, Savoye G, Cadiot G, Flourie B, Capelle P, Marteau P, Lemann M, Colombel JF, Khouri E, Bonaz B, Carbonnel F (2008) Risk factors associated with small bowel adenocarcinoma in Crohn’s disease: a case-control study. Am J Gastroenterol 103:1730–1736

    Article  PubMed  Google Scholar 

  37. von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP (2007) The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum 50:839–855

    Article  Google Scholar 

  38. Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther 23:1097–1104

    Article  PubMed  CAS  Google Scholar 

  39. Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI (2005) Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 100:2724–2729

    Article  PubMed  Google Scholar 

  40. Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A (2002) Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123:1428–1435

    Article  PubMed  Google Scholar 

  41. Howdle PD, Jalal PK, Holmes GK, Houlston RS (2003) Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM 96:345–353

    Article  PubMed  CAS  Google Scholar 

  42. Nicholl MB, Ahuja V, Conway WC, Vu VD, Sim MS, Singh G (2010) Small bowel adenocarcinoma: understaged and undertreated? Ann Surg Oncol 17:2728–2732

    Article  PubMed  Google Scholar 

  43. Koo DH, Yun SC, Hong YS, Ryu MH, Lee JL, Chang HM, Ryoo BY, Kang YK, Kim TW (2011) Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study. BMC Cancer 11:205

  44. Zaanan A, Costes L, Gauthier M, Malka D, Locher C, Mitry E, Tougeron D, Lecomte T, Gornet JM, Sobhani I, Moulin V, Afchain P, Taieb J, Bonnetain F, Aparicio T (2010) Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study. Ann Oncol 21:1786–1793

    Article  PubMed  CAS  Google Scholar 

  45. Khan K, Peckitt C, Sclafani F, Watkins D, Rao S, Starling N, Jain V, Trivedi S, Stanway S, Cunningham D, Chau I (2015) Prognostic factors and treatment outcomes in patients with small bowel adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experience. BMC Cancer 15(15):15

    Article  PubMed  PubMed Central  Google Scholar 

  46. Overman MJ, Kopetz S, Lin E, Abbruzzese JL, Wolff RA (2010) Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. Acta Oncol 49:474–479

    Article  PubMed  Google Scholar 

  47. Mizushima T, Tamagawa H, Mishima H et al (2013) The effects of chemotherapy on primary small bowel cancer: a retrospective multicenter observational study in Japan. Mol Clin Oncol 1:820–824

    Article  PubMed  PubMed Central  Google Scholar 

  48. Guo XC, Mao ZY, Su D, Wang LJ, Zhang TT, Bai L (2014) Retrospective analysis of 119 small bowel adenocarcinoma in Chinese patients. Cancer Investig 32:178–183

    Article  CAS  Google Scholar 

  49. Koo DH, Yun SC, Hong YS, Ryu MH, Lee JL, Chang HM, Kang YK, Kim SC, Han DJ, Lee YJ, Kim TW (2011) Adjuvant chemotherapy for small bowel adenocarcinoma after curative surgery. Oncology (Williston Park) 80:208–213

    Article  CAS  Google Scholar 

  50. Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF (2010) A single-institution experience with 491 cases of small bowel adenocarcinoma. Am J Surg 199:797–803

    Article  PubMed  Google Scholar 

  51. Overman MJ (2013) Rare but real: management of small bowel adenocarcinoma. Am Soc Clin Oncol Educ Book 189–193

  52. Bogaerts J, Sydes MR, Keat N et al (2014) Clinical trial designs for rare diseases: studies developed and discussed by the international rare cancers initiative. Eur J Cancer 51:271–281

    Article  PubMed  Google Scholar 

  53. Valsangkar NP, Ingkakul T, Correa-Gallego C, Mino-Kenudson M, Masia R, Lillemoe KD, Castillo CFD, Warshaw AL, Liss AS, Thayer SP (2015) Survival in ampullary cancer: potential role of different KRAS mutations. Surgery 157:260–268

    Article  PubMed  PubMed Central  Google Scholar 

  54. Kohler I, Jacob D, Budzies J, Lehmann A, Weichert W, Schulz S, Neuhaus P, Röcken C (2011) Phenotypic and genotypic characterization of carcinomas of the papilla of vater has prognostic and putative therapeutic implications. Am J Clin Pathol 135:202–211

    Article  PubMed  Google Scholar 

  55. Schultz NA, Roslind A, Christensen IJ, Horn T, Høgdall E, Pedersen LN, Kruhøffer M, Burcharth F, Wøjdemann M, Johansen JS (2012) Frequencies and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas. Pancreas 41:759–766

    PubMed  CAS  Google Scholar 

  56. Blaker H, von Herbay A, Penzel R, Gross S, Otto HF (2002) Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene. Oncogene 21(1):158–164

    Article  PubMed  CAS  Google Scholar 

  57. Wheeler JM, Warren BF, Mortensen NJ, Kim HC, Biddolph SC, Elia G, Beck NE, Williams GT, Shepherd NA, Bateman AC, Bodmer WF (2002) An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 50(2):218–223

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  58. Schrock AB, Devoe CE, McWilliams R, Sun J, Aparicio T, Stephens PJ, Ross JS, Wilson R, Miller VA, Ali SM, Overman MJ (2017) Genomic profiling of small-bowel adenocarcinoma. JAMA Oncol 3:1546–1553

    Article  PubMed  Google Scholar 

  59. Laforest A, Aparicio T, Zaanan A, Silva FP, Didelot A, Desbeaux A, le Corre D, Benhaim L, Pallier K, Aust D, Pistorius S, Blons H, Svrcek M, Laurent-Puig P (2014) ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma. Eur J Cancer 50:1740–1746

    Article  PubMed  CAS  Google Scholar 

  60. Le DT, Uram JN, Wang H et al (2015) PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372:2509–2520

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  61. Planck M, Ericson K, Piotrowska Z, Halvarsson B, Rambech E, Nilbert M (2003) Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine. Cancer 97:1551–1557

    Article  PubMed  CAS  Google Scholar 

  62. Brueckl WM, Heinze E, Milsmann C, Wein A, Koebnick C, Jung A, Croner RS, Brabletz T, Günther K, Kirchner T, Hahn EG, Hohenberger W, Becker H, Reingruber B (2004) Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine. Cancer Lett 203:181–190

    Article  PubMed  CAS  Google Scholar 

  63. Martin JA, Haber GB (2003) Ampullary adenoma: clinical manifestations, diagnosis, and treatment. Gastrointest Endosc Clin N Am 13:649–669

    Article  PubMed  Google Scholar 

  64. Patel R, Varadarajulu S, Wilcox CM (2012) Endoscopic ampullectomy: techniques and outcomes. J Clin Gastroenterol 46:8–15

    Article  PubMed  CAS  Google Scholar 

  65. Cheng CL, Sherman S, Fogel EL, McHenry L, Watkins JL, Fukushima T, Howard TJ, Lazzell-Pannell L, Lehman GA (2004) Endoscopic snare papillectomy for tumors of the duodenal papillae. Gastrointest Endosc 60:757–764

    Article  PubMed  Google Scholar 

  66. Bellizi et al (2009) The assessmentof specimens procured by endoscopic ampullectomy. Am J Clin Path 132:506–531

    Article  Google Scholar 

  67. Han J, Kim MH (2006) Endoscopic papillectomy for adenomas of the major duodenal papilla (with video). Gastrointest Endosc 63:292–301

    Article  PubMed  Google Scholar 

  68. Yamaguchi K, Enjoji M, Kitamura K (1990) Endoscopic biopsy has limited accuracy in diagnosis of ampullary tumors. Gastrointest Endosc 36:588–592

    Article  PubMed  CAS  Google Scholar 

  69. Kahaleh M, Shami VM, Brock A, Conaway MR, Yoshida C, Moskaluk CA, Adams RB, Tokar J, Yeaton P (2004) Factors predictive of malignancy and endoscopic resectability in ampullary neoplasia. Am J Gastroenterol 99:2335–2339

    Article  PubMed  Google Scholar 

  70. Heinrich S, Clavien PA (2010) Ampullary cancer. Curr Opin Gastroenterol 26:280–285

    Article  PubMed  Google Scholar 

  71. Ahn DW, Ryu JK, Kim J, Yoon WJ, Lee SH, Kim YT, Yoon YB (2013) Endoscopic papillectomy for benign ampullary neoplasms: how can treatment outcome be predicted? Gut Liver 7:239–245

    Article  PubMed  PubMed Central  Google Scholar 

  72. Azih LC, Broussard BL, Phadnis MA, Heslin MJ, Eloubeidi MA, Varadarajulu S, Arnoletti JP (2013) Endoscopic ultrasound evaluation in the surgical treatment of duodenal and peri-ampullary adenomas. World J Gastroenterol 19:511–515

    Article  PubMed  PubMed Central  Google Scholar 

  73. Ang DC, Shia J, Tang LH, Katabi N, Klimstra DS (2014) The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater. Am J Surg Pathol 38:1371–1379

    Article  PubMed  Google Scholar 

  74. Xue Y, Reid MD, Balci S, Quigley B, Muraki T, Memis B, Xia J, Hacihasanoglu E, Bedolla G, Pehlivanoglu B, Kim GE, Tajiri T, Ohike N, Aneja R, Krasinskas AM, Adsay V (2017) Immunohistochemical classification of ampullary carcinomas: critical reappraisal fails to confirm prognostic relevance for recently proposed panels, and highlights MUC5AC as a strong prognosticator. Am J Surg Pathol 41:865–876

    Article  PubMed  Google Scholar 

  75. Perysinakis I, Margaris I, Kouraklis G (2014) Ampullary cancer—a separate clinical entity? Histopathology 64:759–768

    Article  PubMed  Google Scholar 

  76. Adsay V, Ohike N, Tajiri T, Kim GE, Krasinskas A, Balci S, Bagci P, Basturk O, Bandyopadhyay S, Jang KT, Kooby DA, Maithel SK, Sarmiento J, Staley CA, Gonzalez RS, Kong SY, Goodman M (2012) Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases. Am J Surg Pathol 36:1592–1608

    Article  PubMed  Google Scholar 

  77. Aparicio T, Zaanan A, Svrcek M et al (2014) Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 46:97–104

    Article  Google Scholar 

  78. Bronsert P, Kohler I, Werner M, Makowiec F, Kuesters S, Hoeppner J, Hopt UT, Keck T, Bausch D, Wellner UF (2013) Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin. BMC Cancer 13(428)

  79. Carter JT, Grenert JP, Rubenstein L, Stewart L, Way LW (2008) Tumors of the ampulla of vater: histopathologic classification and predictors of survival. J Am Coll Surg 207:210–218

    Article  PubMed  Google Scholar 

  80. Chang DK, Jamieson NB, Johns AL, Scarlett CJ, Pajic M, Chou A, Pinese M, Humphris JL, Jones MD, Toon C, Nagrial AM, Chantrill LA, Chin VT, Pinho AV, Rooman I, Cowley MJ, Wu J, Mead RS, Colvin EK, Samra JS, Corbo V, Bassi C, Falconi M, Lawlor RT, Crippa S, Sperandio N, Bersani S, Dickson EJ, Mohamed MAA, Oien KA, Foulis AK, Musgrove EA, Sutherland RL, Kench JG, Carter CR, Gill AJ, Scarpa A, McKay CJ, Biankin AV (2013) Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. J Clin Oncol 31:1348–1356

    Article  PubMed  Google Scholar 

  81. Kim WS, Choi DW, Choi SH, Heo JS, You DD, Lee HG (2012) Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer. J Surg Oncol 105:266–272

    Article  PubMed  Google Scholar 

  82. Kimura W, Futakawa N, Yamagata S, Wada Y, Kuroda A, Muto T, Esaki Y (1994) Different clinicopathologic findings in two histologic types of carcinoma of papilla of vater. Jpn J Cancer Res 85:161–166

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  83. Roh YH, Kim YH, Lee HW, Kim SJ, Roh MS, Jeong JS, Jung GJ (2007) The clinicopathologic and immunohistochemical characteristics of ampulla of vater carcinoma: the intestinal type is associated with a better prognosis. Hepato-Gastroenterology 54:1641–1644

    PubMed  Google Scholar 

  84. Westgaard A, Pomianowska E, Clausen OP, Gladhaug IP (2013) Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies? Ann Surg Oncol 20:430–439

    Article  PubMed  Google Scholar 

  85. Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OPF, Gladhaug IP (2008) Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMC Cancer 8(170)

  86. Zhou H, Schaefer N, Wolff M, Fischer HP (2004) Carcinoma of the ampulla of vater: comparative histologic/immunohistochemical classification and follow-up. Am J Surg Pathol 28:875–882

    Article  PubMed  Google Scholar 

  87. Howe JR, Klimstra DS, Moccia RD, Conlon KC, Brennan MF (1998) Factors predictive of survival in ampullary carcinoma. Ann Surg 228:87–94

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  88. Schueneman A, Goggins M, Ensor J, Saka B, Neishaboori N, Lee S, Maitra A, Varadhachary G, Rezaee N, Wolfgang C, Adsay V, Wang H, Overman MJ (2015) Validation of histomolecular classification utilizing histological subtype, muc1, and cdx2 for prognostication of resected ampullary adenocarcinoma. Br J Cancer 113:64–68

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  89. Schiergens TS, Reu S, Neumann J, Renz BW, Niess H, Boeck S, Heinemann V, Bruns CJ, Jauch KW, Kleespies A (2015) Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of vater. Surgery 158:151–161

    Article  PubMed  Google Scholar 

  90. Amin Mb, ed. AJCC cancer staging manual, 2017, Springer

  91. Balachandran P, Sikora SS, Kapoor S, Krishnani N, Kumar A, Saxena R, Kapoor VK (2006) Long-term survival and recurrence patterns in ampullary cancer. Pancreas 32:390–395

    Article  PubMed  Google Scholar 

  92. Hsu HP, Yang TM, Hsieh YH, Shan YS, Lin PW (2007) Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer. Ann Surg Oncol 14:50–60

    Article  PubMed  Google Scholar 

  93. Hsu HP, Shan YS, Hsieh YH, Yang TM, Lin PW (2007) Predictors of recurrence after pancreaticoduodenectomy in ampullary cancer: comparison between non-, early and late recurrence. J Formos Med Assoc 106:432–443

    Article  PubMed  CAS  Google Scholar 

  94. Todoroki T, Koike N, Morishita Y, Kawamoto T, Ohkohchi N, Shoda J, Fukuda Y, Takahashi H (2003) Patterns and predictors of failure after curative resections of carcinoma of the ampulla of vater. Ann Surg Oncol 10:1176–1183

    Article  PubMed  Google Scholar 

  95. Kim RD, Kundhal PS, McGilvray ID et al (2006) Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg 202:112–119

    Article  PubMed  Google Scholar 

  96. Winter JM, Cameron JL, Olino K, Herman JM, de Jong MC, Hruban RH, Wolfgang CL, Eckhauser F, Edil BH, Choti MA, Schulick RD, Pawlik TM (2010) Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointes Surg 14:379–387

    Article  Google Scholar 

  97. Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Jang JY, Kim SW, Kang GH, Yoon YB (2007) Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol 14:3195–3201

    Article  PubMed  Google Scholar 

  98. Kang HJ, Eo SH, Kim SC, Park KM, Lee YJ, Lee SK, Yu E, Cho HJ, Hong SM (2014) Increased number of metastatic lymph nodes in adenocarcinoma of the ampulla of vater as a prognostic factor: a proposal of new nodal classification. Surgery 155:74–84

    Article  PubMed  Google Scholar 

  99. Ohike N, Coban I, Kim GE, Basturk O, Tajiri T, Krasinskas A, Bandyopadhyay S, Morohoshi T, Shimada Y, Kooby DA, Staley CA, Goodman M, Volkan Adsay N (2010) Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas. Am J Surg Pathol 34:1417–1424

    Article  PubMed  PubMed Central  Google Scholar 

  100. Bhatia S, Miller RC, Haddock MG, Donohue JH, Krishnan S (2006) Adjuvant therapy for ampullary carcinomas: the mayo clinic experience. Int J Radiat Oncol Biol Phys 66:514–519

    Article  PubMed  Google Scholar 

  101. Lee JH, Whittington R, Williams NN, Berry MF, Vaughn DJ, Haller DG, Rosato EF (2000) Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol Biol Phys 47:945–953

    Article  PubMed  CAS  Google Scholar 

  102. Kim K, Chie EK, Jang JY, Kim SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW (2009) Role of adjuvant chemoradiotherapy for ampulla of vater cancer. Int J Radiat Oncol Biol Phys 75:436–441

    Article  PubMed  CAS  Google Scholar 

  103. Palta M, Patel P, Broadwater G, Willett C, Pepek J, Tyler D, Zafar SY, Uronis H, Hurwitz H, White R, Czito B (2012) Carcinoma of the ampulla of vater: patterns of failure following resection and benefit of chemoradiotherapy. Ann Surg Oncol 19:1535–1540

    Article  PubMed  Google Scholar 

  104. Jabbour SK, Mulvihill D (2014) Defining the role of adjuvant therapy: ampullary and duodenal adenocarcinoma. Semin Radiat Oncol 24:85–93

    Article  PubMed  Google Scholar 

  105. Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt NC, Dervenis C, Smith D, Glimelius B, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Ghaneh P, Halloran CM, Lerch MM, Oláh A, Rawcliffe CL, Verbeke CS, Campbell F, Büchler MW, European Study Group for Pancreatic Cancer (2012) Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA 308:147–156

  106. Hechtman JF, Liu W, Sadowska J, Zhen L, Borsu L, Arcila ME, Won HH, Shah RH, Berger MF, Vakiani E, Shia J, Klimstra DS (2015) Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of erbb2 (her2). Mod Pathol 28:1123–1129

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  107. Alvi MA, McArt DG, Kelly P, Fuchs MA, Alderdice M, McCabe C, Bingham V, McGready C, Tripathi S, Emmert-Streib F, Loughrey MB, McQuaid S, Maxwell P, Hamilton PW, Turkington R, James JA, Wilson RH, Salto-Tellez M (2015) Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility. Oncotarget 6:20863–20874

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Histopathology Department, St. James’s Hospital, Dublin 2, Ireland

    Aoife Maguire

  2. Pathology Department, & Centre for Colorectal Disease, UCD Medical School, St. Vincent’s University Hospital, Dublin, Ireland

    Kieran Sheahan

Authors
  1. Aoife Maguire
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kieran Sheahan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kieran Sheahan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maguire, A., Sheahan, K. Primary small bowel adenomas and adenocarcinomas—recent advances. Virchows Arch 473, 265–273 (2018). https://doi.org/10.1007/s00428-018-2400-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-018-2400-7

Keywords

Search

Navigation